White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters

Neurobiology of Aging

Volumn 36, Issue 9, 2015, Pages 2447-2457

  Lindemer, Emily R ^a,b   Salat, David H ^b,c   Smith, Eric E ^d   Nguyen, Khoa ^b   Fischl, Bruce ^a,b,e   Greve, Douglas N ^b  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alzheimer's disease; Alzheimer's Disease Neuroimaging initiative; FreeSurfer; Hippocampus; Mild cognitive impairment; White matter signal abnormality

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER INJURY; WHITE MATTER SIGNAL ABNORMALITY; ANALYSIS OF VARIANCE; COGNITIVE DEFECT; IMAGE PROCESSING; MENTAL HEALTH; PATHOLOGY; PATHOPHYSIOLOGY; VERY ELDERLY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; COGNITIVE DYSFUNCTION; CROSS-SECTIONAL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; WHITE MATTER;

EID: 84940467112     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.05.011     Document Type: Article

References (80)

1. Barber R., Scheltens P., Gholkar A., Ballard C., McKeith I., Ince P., Perry R., O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J. Neurol. Neurosurg. Psychiatry 1999, 67:66-72.
2. Barker R., Ashby E.L., Wellington D., Barrow V.M., Palmer J.C., Kehoe P.G., Esiri M.M., Love S. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 2014, 137(Pt 5):1524-1532.
3. Bocti C., Swartz R.H., Gao F.-Q., Sahlas D.J., Behl P., Black S.E. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke 2005, 36:2126-2131.
4. Bowen B.C., Barker W.W., Loewenstein D.A., Sheldon J., Duara R. MR signal abnormalities in memory disorder and dementia. AJR Am. J. Roentgenol. 1990, 11:283-290.
5. Brickman A.M., Muraskin J., Zimmerman M.E. Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter?. Dialogues Clin. Neurosci. 2009, 11:181-190.
6. Brickman A.M., Provenzano F.A., Muraskin J., Manly J.J., Blum S., Apa Z., Stern Y., Brown T.R., Luchsinger J.A., Mayeux R. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch. Neurol. 2012, 69:1621-1627.
7. Brickman A.M., Zahra A., Muraskin J., Steffener J., Holland C.M., Habeck C., Borogovac A., Ramos M.A., Brown T.R., Asllani I., Stern Y. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res. 2009, 172:117-120.
8. Canu E., Frisoni G.B., Agosta F., Pievani M., Bonetti M., Filippi M. Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage. Neurobiol. Aging 2012, 33:1023-1033.
9. Carmichael O., Schwarz C., Drucker D., Fletcher E., Harvey D., Beckett L., Jack C.R., Weiner M., DeCarli C. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch. Neurol. 2010, 67:1370-1378.
10. Caroli A., Testa C., Geroldi C., Nobili F., Guerra U.P., Bonetti M., Frisoni G.B. Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment. J. Neurol. 2007, 254:1000-1008.
11. Cerasa A., Bilotta E., Augimeri A., Cherubini A., Pantano P., Zito G., Lanza P., Valentino P., Gioia M.C., Quattrone A. A Cellular Neural Network methodology for the automated segmentation of multiple sclerosis lesions. J. Neurosci. Methods 2012, 203:193-199.
12. Chen J.J., Rosas H.D., Salat D.H. The relationship between cortical blood flow and sub-cortical white-matter health across the adult age span. PLoS One 2013, 8:e56733.
13. Convit A., De Leon M.J., Tarshish C., De Santi S., Tsui W., Rusinek H., George A. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol. Aging 1997, 18:131-138.
14. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9:179-194.
15. Dale A.M., Sereno M.I. Improved localizadon of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J. Cogn. Neurosci. 1993, 5:162-176.
16. Debette S., Markus H.S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010, 341:c3666.
17. DeCarli C., Grady C.L., Clark C.M., Katz D.A., Brady D.R., Murphy D.G., Haxby J.V., Salerno J.A., Gillette J.A., Gonzalez-Aviles A., Rapoport S.I. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J. Neurol. Neurosurg. Psychiatry 1996, 60:158-167.
18. DeCarli C., Massaro J., Harvey D., Hald J., Tullberg M., Au R., Beiser A., D'Agostino R., Wolf P.A. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol. Aging 2005, 26:491-510.
19. Delano-Wood L., Bondi M.W., Sacco J., Abeles N., Jak A.J., Libon D.J., Bozoki A. Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology. J. Int. Neuropsychol. Soc. 2009, 15:906-914.
20. De Leeuw F.E., de Groot J.C., Achten E., Oudkerk M., Ramos L.M., Heijboer R., Hofman A., Jolles J., van Gijn J., Breteler M.M. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry 2001, 70:9-14.
21. Dickerson B.C., Goncharova I., Sullivan M.P., Forchetti C., Wilson R.S., Bennett D.A., Beckett L.A., DeToledo-Morrell L. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol. Aging 2001, 22:747-754.
22. Erten-Lyons D., Woltjer R., Kaye J., Mattek N., Dodge H.H., Green S., Tran H., Howieson D.B., Wild K., Silbert L.C. Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology 2013, 81:977-983.
23. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11050-11055.
24. Fischl B., Liu A., Dale A.M. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans. Med. Imaging 2001, 20:70-80.
25. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
26. Fischl B., Salat D.H., Van Der Kouwe A., Makris N., Segonne F., Quinn B.T., Dale A.M. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14:11-22.
27. Fischl B., Sereno M.I., Tootell R.B.H., Dale A.M. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 1999, 8:272-284.
28. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Ségonne F., Salat D.H., Busa E., Seidman L.J., Goldstein J., Kennedy D., Caviness V., Makris N., Rosen B., Dale A.M. Sequence-independent segmentation of magnetic resonance images. Neuroimage 2004, 23:S69-S84.
29. Frisoni G.B., Galluzzi S., Pantoni L., Filippi M. The effect of white matter lesions on cognition in the elderly - small but detectable. Nat. Clin. Pract. Neurol. 2007, 3:620-627.
30. García-Lorenzo D., Francis S., Narayanan S., Arnold D.L., Collins D.L. Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging. Med. Image Anal. 2013, 17:1-18.
31. García-Lorenzo D., Lecoeur J., Arnold D.L., Collins D.L., Barillot C. Multiple sclerosis lesion segmentation using an automatic multimodal graph cuts. Med. Image Comput. Comput. Assist. Interv. 2009, 12(Pt 2):584-591.
32. García-lorenzo D., Prima S., Collins D., Arnold D., Morrissey S., Barillot C. Combining Robust Expectation Maximization and Mean Shift Algorithms for Multiple Sclerosis Brain Segmentation 2008, 82-91. New York, "Processin.
33. Gosche K.M., Mortimer J.A., Smith C.D., Markesbery W.R., Snowdon D.A. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 2002, 58:1476-1482.
34. Gouw A.A., Seewann A., van der Flier W.M., Barkhof F., Rozemuller A.M., Scheltens P., Geurts J.J.G. Heterogeneity of small vessel disease: a systematicreview of MRI and histopathology correlations. J. Neurol. Neurosurg. Psychiatry 2011, 82:126-135.
35. Grimaud J., Lai M., Thorpe J., Adeleine P., Wang L., Barker G.J., Plummer D.L., Tofts P.S., McDonald W.I., Miller D.H. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn. Reson. Imaging 1996, 14:495-505.
36. Grimmer T., Faust M., Auer F., Alexopoulos P., Förstl H., Henriksen G., Perneczky R., Sorg C., Yousefi B.H., Drzezga A., Kurz A. White matter hyperintensities predict amyloid increase in Alzheimer's disease. Neurobiol. Aging 2012, 33:2766-2773.
37. Grueter B.E., Schulz U.G. Age-related cerebral white matter disease (leukoaraiosis): a review. Postgrad. Med. J. 2012, 88:79-87.
38. Gurol M.E., Irizarry M.C., Smith E.E., Raju S., Diaz-Arrastia R., Bottiglieri T., Rosand J., Growdon J.H., Greenberg S.M. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006, 66:23-29.
39. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., Busa E., Pacheco J., Albert M., Killiany R., Maguire P., Rosas D., Makris N., Dale A., Dickerson B., Fischl B. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006, 32:180-194.
40. Huang H., Fan X., Weiner M., Martin-Cook K., Xiao G., Davis J., Devous M., Rosenberg R., Diaz-Arrastia R. Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization. Neurobiol. Aging 2012, 33:2029-2045.
41. Huang Y.H., Zhang W.W., Lin L., Feng J., Zhao X.X., Guo W.H., Wei W. Could changes in arterioles impede the perivascular drainage of interstitial fluid from the cerebral white matter in leukoaraiosis?. Neuropathol. Appl. Neurobiol. 2010, 36:237-247.
42. Iadecola C. The pathobiology of vascular dementia. Neuron 2013, 80:844-866.
43. Jack C.R., Bernstein M.A., Fox N.C., Thompson P., Alexander G., Harvey D., Borowski B., Britson P.J., Whitwell J.L., Ward C., Dale A.M., Felmlee J.P., Gunter J.L., Hill D.L.G., Killiany R., Schuff N., Fox-Bosetti S., Lin C., Studholme C., DeCarli C.S., Krueger G., Ward H.A., Metzger G.J., Scott K.T., Mallozzi R., Blezek D., Levy J., Debbins J.P., Fleisher A.S., Albert M., Green R., Bartzokis G., Glover G., Mugler J., Weiner M.W. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 2008, 27:685-691.
44. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T.G., Pankratz V.S., Donohue M.C., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
45. Jack C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E.G., Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52:1397-1403.
46. Jovicich J., Czanner S., Greve D., Haley E., Van Der Kouwe A., Gollub R., Kennedy D., Schmitt F., Brown G., MacFall J., Fischl B., Dale A. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006, 30:436-443.
47. Levy-Cooperman N., Ramirez J., Lobaugh N.J., Black S.E. Misclassified tissue volumes in Alzheimer disease patients with white matter hyperintensities: importance of lesion segmentation procedures for volumetric analysis. Stroke 2008, 39:1134-1141.
48. Mahalanobis P.C. On the generalised distance in statistics. Proc. Natl. Inst. Sci. India 1936, 2:49-55.
49. Maillard P., Carmichael O., Harvey D., Fletcher E., Reed B., Mungas D., DeCarli C. FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am. J. Neuroradiol. 2013, 34:54-61.
50. Maillard P., Delcroix N., Crivello F., Dufouil C., Gicquel S., Joliot M., Tzourio-Mazoyer N., Alpérovitch A., Tzourio C., Mazoyer B. An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. Neuroradiology 2008, 50:31-42.
51. Maillard P., Fletcher E., Lockhart S.N., Roach A.E., Reed B., Mungas D., DeCarli C., Carmichael O.T. White matter hyperintensities and their penumbra lie along a continuum of injury in the aging brain. Stroke 2014, 45:1721-1726.
52. MATLAB and Statistics Toolbox Release 2013, MATLAB version R2013b, The MathWorks, Inc., Natick, Massachusetts, United States.
53. Medina D., DeToledo-Morrell L., Urresta F., Gabrieli J.D.E., Moseley M., Fleischman D., Bennett D.A., Leurgans S., Turner D.A., Stebbins G.T. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol. Aging 2006, 27:663-672.
54. Mortazavi D., Kouzani A.Z., Soltanian-Zadeh H. Segmentation of multiple sclerosis lesions in MR images: a review. Neuroradiology 2012, 54:299-320.
55. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010, 9:689-701.
56. Pettersen J.A., Sathiyamoorthy G., Gao F.-Q., Szilagyi G., Nadkarni N.K., St George-Hyslop P., Rogaeva E., Black S.E. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch. Neurol. 2008, 65:790-795.
57. Pievani M., Agosta F., Pagani E., Canu E., Sala S., Absinta M., Geroldi C., Ganzola R., Frisoni G.B., Filippi M. Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum. Brain Mapp. 2010, 31:1862-1875.
58. Prins N.D., van Dijk E.J., den Heijer T., Vermeer S.E., Koudstaal P.J., Oudkerk M., Hofman A., Breteler M.M.B. Cerebral white matter lesions and the risk of dementia. Arch. Neurol. 2004, 61:1531-1534.
59. Reuter M., Rosas H.D., Fischl B. Highly accurate inverse consistent registration: a robust approach. Neuroimage 2010, 53:1181-1196.
60. Reuter M., Schmansky N.J., Rosas H.D., Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 2012, 61:1402-1418.
61. Schuff N., Woerner N., Boreta L., Kornfield T., Shaw L.M., Trojanowski J.Q., Thompson P.M., Jack C.R., Weiner M.W. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 2009, 132:1067-1077.
62. Schwarz C., Fletcher E., DeCarli C., Carmichael O. Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. Inf. Process. Med. Imaging 2009, 21:239-251.
63. Sheltens P., Barkhof F., Valk J., Algra P.R., Van der Hoop R.G., Nauta J., Wolters E.C. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992, 115:735-748.
64. Shi F., Liu B., Zhou Y., Yu C., Jiang T. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: meta-analyses of MRI studies. Hippocampus 2009, 19:1055-1064.
65. Silbert L.C., Dodge H.H., Perkins L.G., Sherbakov L., Lahna D., Erten-Lyons D., Woltjer R., Shinto L., Kaye J.A. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 2012, 79:741-747.
66. Smith E.E., Egorova S., Blacker D., Killiany R.J., Muzikansky A., Dickerson B.C., Tanzi R.E., Albert M.S., Greenberg S.M., Guttmann C.R.G. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch. Neurol. 2008, 65:94-100.
67. Spilt A., Goekoop R., Westendorp R.G.J., Blauw G.J., de Craen A.J.M., van Buchem M.A. Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study. AJNR Am. J. Neuroradiol. 2006, 27:1964-1968.
68. Tanabe J.L., Amend D., Schuff N., DiSclafani V., Ezekiel F., Norman D., Fein G., Weiner M.W. Tissue segmentation of the brain in Alzheimer disease. AJNR Am. J. Neuroradiol. 1997, 18:115-123.
69. Topakian R., Barrick T., Howe F., Markus H. Blood-brain barrier permeability is increased in normal appearing white matter in patients with lacunar stroke and leukoaraiosis. J. Neurol. Neurosurg. Psychiatry 2010, 81:1-26.
70. Tosto G., Zimmerman M.E., Carmichael O.T., Brickman A.M. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol. 2014, 71:872-877.
71. Tullberg M., Fletcher E., DeCarli C., Mungas D., Reed B.R., Harvey D.J., Weiner M.W., Chui H.C., Jagust W.J. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004, 63:246-253.
72. Van de Pol L.A., Verhey F., Frisoni G.B., Tsolaki M., Papapostolou P., Nobili F., Wahlund L.-O., Minthon L., Frölich L., Hampel H., Soininen H., Knol D.L., Barkhof F., Scheltens P., Visser P.J. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study. J. Neurol. Neurosurg. Psychiatry 2009, 80:1069-1074.
73. Van Straaten E.C.W., Fazekas F., Rostrup E., Scheltens P., Schmidt R., Pantoni L., Inzitari D., Waldemar G., Erkinjuntti T., Mäntylä R., Wahlund L.-O., Barkhof F. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006, 37:836-840.
74. Viswanathan A. Shades of white: separating degrees of injury in the aging brain. Stroke 2014, 45:1606-1607.
75. Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R., Lindley R.I., O'Brien J.T., Barkhof F., Benavente O.R., Black S.E., Brayne C., Breteler M., Chabriat H., Decarli C., de Leeuw F.-E., Doubal F., Duering M., Fox N.C., Greenberg S., Hachinski V., Kilimann I., Mok V., Oostenbrugge R.v., Pantoni L., Speck O., Stephan B.C.M., Teipel S., Viswanathan A., Werring D., Chen C., Smith C., van Buchem M., Norrving B., Gorelick P.B., Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013, 12:822-838.
76. Wolf H., Ecke G.M., Bettin S., Dietrich J., Gertz H.J. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int. J. Geriatr. Psychiatry 2000, 15:803-812.
77. Xie S., Xiao J.X., Gong G.L., Zang Y.F., Wang Y.H., Wu H.K., Jiang X.X. Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 2006, 66:1845-1849.
78. Yoshita M., Fletcher E., Harvey D., Ortega M., Martinez O., Mungas D.M., Reed B.R., DeCarli C.S. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006, 67:2192-2198.
79. Young V.G., Halliday G.M., Kril J.J. Neuropathologic correlates of white matter hyperintensities. Neurology 2008, 71:804-811.
80. Zijdenbos A.P., Dawant B.M., Margolin R.A., Palmer A.C. Morphometric analysis of white matter lesions in MR images: method and validation. IEEE Trans. Med. Imaging 1994, 13:716-724.